Personalis, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Personalis, Inc.
Quantité totale PI 146
Rang # Quantité totale PI 9 072
Note d'activité PI 2,9/5.0    113
Rang # Activité PI 6 005
Symbole boursier
ISIN US71535D1063
Capitalisation 293M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

51 32
0 21
15 25
2
 
Dernier brevet 2025 - Customized assays for personaliz...
Premier brevet 2013 - Methods and systems for genetic ...
Dernière marque 2023 - NEOPS
Première marque 2012 - PERSONALIS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Customized assays for personalized cancer monitoring. The present disclosure provides methods an...
Invention Methods for using mosaicism in nucleic acids sampled distal to their origin. Disclosed herein ar...
Invention Methods and systems for genetic analysis. This disclosure provides systems and methods for sampl...
2024 Invention Estimating tumor purity from single samples. The disclosure provides methods for estimating tumo...
Invention Methods and systems for genetic analysis. This disclosure provides systems and methods for sample...
Invention Methods for using mosaicism in nucleic acids sampled distal to their origin. Disclosed herein are...
Invention Methods and systems for genomic analysis. A computer-implemented method for processing and/or an...
2023 P/S Diagnostic biomarker reagents for medical purposes Providing data analysis and interpretation of ...
Invention Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples....
Invention Methods and system for using methylation data for disease detection and quantification. Provided ...
2022 Invention Machine-learning techniques for predicting surface-presenting peptides. The disclosure provides ...
P/S Providing genome sequencing, data analysis and interpretation, assay development and preparing, a...
Invention Determining fragmentomic signatures based on latent variables of nucleic acid molecules. A metho...
Invention Determining fragmentomic signatures based on latent variables of nucleic acid molecules. A method...
P/S Providing genome sequencing, data analysis and interpretation, assay development and preparing, ...
Invention Composite biomarkers for immunotherapy for cancer. Methods for generating a composite biomarker ...
Invention Customized assays for personalized cancer monitoring. The present disclosure provides methods and...
Invention Methods of treating kras mutation subtypes with cd40 agonist. The present disclosure provides met...
Invention Methods and systems for genomic analysis. A computer-implemented method for processing and/or ana...
Invention Somatic variant calling from an unmatched biological sample. Methods for somatic variant calling...
Invention Estimating tumor purity from single samples. The disclosure provides methods for estimating tumor...
Invention Detecting loss of heterozygosity in hla alleles using machine-learning models. A method of detec...
Invention Detecting loss of heterozygosity in hla alleles using machine-learning models. A method of detect...
2021 Invention Personalized genetic testing. The present disclosure provides methods and systems for personaliz...
Invention Machine-learning techniques for predicting surface-presenting peptides. The disclosure provides m...
Invention Composite biomarkers for immunotherapy for cancer. Methods for generating a composite biomarker t...
P/S Design of algorithms and models for use in scientific and medical research, all in the field of b...
P/S Design of algorithms and models for use in scientific and medical research, all in the field of ...
2020 Invention Methods for analyzing genotypes. The disclosure provides methods and systems for analyzing genoty...
Invention Somatic variant calling from an unmatched biological sample. Methods for somatic variant calling ...